Stocks sell off - what I am looking at
Stocks sell off, with an update on SMC and other ideas.
Stocks sell off, with an update on SMC and other ideas.
Zscaler stock jumps 18% on report that CrowdStrike in talks to buy security vendor $ZS $CRWD
BJ’s Wholesale Raises Outlook, But Promotions Weigh on Margins $BJ
Take-Two’s ‘Grand Theft Auto VI’ Hits Nearly $4 Billion in Sales on Launch Day $TTWO
@yenoms One of us! One of us!! $VNO Pref Gang
AppLovin’s e-commerce advertiser base doubled to 22,061 stores since August, lifting CPMs roughly 46% as more products monetize previously…
Natera grew Q3 revenue 34% to $794 million, raised 2026 guidance to $3.005 billion to $3.035 billion, and named oncology head Solomon…
Intuit’s $3.68 billion Mailchimp sale removes a noncore unit as TurboTax shifts to assisted filing and Credit Karma faces volume pressure.
Netflix’s WWE deal pairs 52 weeks of programming with its ad-supported tier, while Peter Rice takes over content amid layoffs and Bela…
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual…
Qualcomm’s Q4 FY2026 review assesses its semiconductor business, moat, financials and valuation amid a chip-sector rebound.
Intuit shares fell 9.8% after chatbots slowed Credit Karma, while QuickBooks grew mid-teens and FY27 guidance stayed unchanged.
BUR · long Burford Capital is presented as a long investment idea.
Adobe investment case summary.
Deere raised net income and cash flow guidance despite a 10% Production and Precision Ag sales decline, as construction and small-ag…
IRhythm’s ZEUS clearance cuts clinician review time 50%, targeting $100 million in five-year savings as cardiac monitoring margins expand…
Stabilis Solutions lost its Galveston LNG offtake anchor, revenue fell 36% in 1H’26, and limited liquidity leaves its data-center power…
Real Brokerage’s RE/MAX acquisition would triple its agent count, diversify revenue with franchise fees and expand share during a weak U.S.
Corcept Therapeutics expects Lifyorli and Korlym to support 44% revenue growth, while FDA and European decisions on relacorilant could…
El Al trades near 2x EBITDA after wartime near-monopoly profits, with $1.3 billion of net cash and owned aircraft weighed against…
Bank of America’s BAC.PR.B yields just over 6% near par, while discounted lower-coupon series such as BAC.PR.P offer better value despite…
Moderna's Phase 3 intismeran autogene trial met its recurrence-free survival endpoint in adjuvant melanoma, supporting an asymmetric…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.